10 Practical Takeaways From FDA's Biopharma AI Guidance
By Joe Franklin, Olivia Dworkin and Sarah Cowlishaw · March 21, 2025, 6:26 PM EDT
An increasing number of regulatory submissions made to the U.S. Food and Drug Administration by drug and biological product manufacturers have included artificial intelligence elements....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login